Avinger announces conversion of $11 million of crg debt into preferred equity

Redwood city, ca / accesswire / may 16, 2024 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with crg partners iii l.p. ("crg") into a shares of a new series of convertible preferred stock.
AVGR Ratings Summary
AVGR Quant Ranking